Recursion Pharmaceuticals

Recursion Pharmaceuticals

Recursion Pharmaceuticals

Combining experimental biology and bioinformatics to identify 100 new treatmentsin 10 years.
Type
B2c
Founded
2013
Raised
$100.6M
Follow us
Alexa global traffic share
Twitter followers
04 Oct 2017
$60,000,000
Venture capital (Series B)

Drug discovery startup Recursion raises $60 million in Series B from Data Collective 

TechCrunch
+1
03 Oct 2016
$12,900,000
Venture capital (Series A)

Recursion Pharmaceuticals Raises $13M to Discover New Drugs Using Artificial Intelligence | Business Wire

businesswire
+1
23 Feb 2015
$830,000
Debt financing
15 Aug 2014
$170,000
Seed fund